Biyo Pharma

Hangzhou, China · Founded 2021 · Privately Held (backing)

Developer of innovative drug designed for nervous system disease. Biyo Pharma is based in Hangzhou, China and was founded in 2021. It has raised $14.3 million.

Last price · $/share

—

Implied valuation

—

Total raised

$14.3M

Last round

—

How much has Biyo Pharma raised?

$14.3Macross 0 recorded rounds

Free account

More of Biyo Pharma with a free account

·Watch Biyo Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Biyo Pharma investors

8 investors are on record for Biyo Pharma, including Lapam Capital, Tailong VC, Hangzhou Capital and Shanghai Healthcare Capital.

For fundraisers

Raising for a company like Biyo Pharma?

8 investors have backed Biyo Pharma.

See all 8 investors →

Frequently asked about Biyo Pharma

How much has Biyo Pharma raised?: Biyo Pharma has raised $14.3M in total across 0 recorded funding rounds.